BioAtla, Inc. (BCAB)

BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $39.46 million. The enterprise value is $28.94 million.

Market Cap	39.46M
Enterprise Value	28.94M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

BioAtla has 58.72 million shares outstanding. The number of shares has increased by 11.77% in one year.

Current Share Class	58.72M
Shares Outstanding	58.72M
Shares Change (YoY)	+11.77%
Shares Change (QoQ)	+0.44%
Owned by Insiders (%)	8.37%
Owned by Institutions (%)	14.23%
Float	45.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.52
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.63
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.24

Current Ratio	1.24
Quick Ratio	1.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -813.88% and return on invested capital (ROIC) is -353.86%.

Return on Equity (ROE)	-813.88%
Return on Assets (ROA)	-82.52%
Return on Invested Capital (ROIC)	-353.86%
Return on Capital Employed (ROCE)	-600.43%
Revenue Per Employee	$180,328
Profits Per Employee	-$975,656
Employee Count	61
Asset Turnover	0.23
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.09% in the last 52 weeks. The beta is 0.91, so BioAtla's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-58.09%
50-Day Moving Average	0.44
200-Day Moving Average	0.52
Relative Strength Index (RSI)	67.19
Average Volume (20 Days)	1,061,726

Short Selling Information

The latest short interest is 3.98 million, so 6.77% of the outstanding shares have been sold short.

Short Interest	3.98M
Short Previous Month	4.44M
Short % of Shares Out	6.77%
Short % of Float	8.76%
Short Ratio (days to cover)	6.82

Income Statement

In the last 12 months, BioAtla had revenue of $11.00 million and -$59.52 million in losses. Loss per share was -$1.11.

Revenue	11.00M
Gross Profit	-51.19M
Operating Income	-63.22M
Pretax Income	-104.56M
Net Income	-59.52M
EBITDA	-62.47M
EBIT	-63.22M
Loss Per Share	-$1.11

Balance Sheet

The company has $18.21 million in cash and $6.05 million in debt, giving a net cash position of $12.16 million or $0.21 per share.

Cash & Cash Equivalents	18.21M
Total Debt	6.05M
Net Cash	12.16M
Net Cash Per Share	$0.21
Equity (Book Value)	-16.75M
Book Value Per Share	-0.29
Working Capital	4.01M

Cash Flow

Operating Cash Flow	-52.32M
Capital Expenditures	n/a
Free Cash Flow	-52.32M
FCF Per Share	-$0.89

Margins

Gross Margin	n/a
Operating Margin	-574.72%
Pretax Margin	-541.05%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.77%
Shareholder Yield	-11.77%
Earnings Yield	-144.79%
FCF Yield	-127.29%

Analyst Forecast

The average price target for BioAtla is $1.00, which is 48.83% higher than the current price. The consensus rating is "Hold".

Price Target	$1.00
Price Target Difference	48.83%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-7.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioAtla has an Altman Z-Score of -33.21 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-33.21
Piotroski F-Score	1